CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

Massive difference indeed. The first approval was only for the...

  1. 45 Posts.
    Massive difference indeed. The first approval was only for the T315i mutation, which was estimated at no more than 500 in the US. The new NDA will target a larger population (ALL whom have failed 2 or more TKIs), with a population most certainly in the 1000's and growing. In conclusion, the 70cent offer is a joke, but it does put Greg into the millionare category.
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.